S&P 500   4,544.90 (-0.11%)
DOW   35,677.02 (+0.21%)
QQQ   374.10 (-0.84%)
AAPL   148.69 (-0.53%)
MSFT   309.16 (-0.51%)
FB   324.61 (-5.05%)
GOOGL   2,751.33 (-3.04%)
TSLA   909.68 (+1.75%)
AMZN   3,335.55 (-2.90%)
NVDA   227.26 (+0.15%)
BABA   177.70 (+0.16%)
NIO   38.88 (-2.73%)
CGC   13.38 (-4.70%)
GE   104.05 (+0.87%)
AMD   119.82 (+0.41%)
MU   67.51 (-1.65%)
T   25.49 (-1.05%)
F   16.28 (-1.63%)
ACB   7.07 (-4.07%)
DIS   169.42 (-1.12%)
PFE   43.16 (+0.70%)
BA   212.97 (-0.64%)
AMC   36.60 (-6.73%)
S&P 500   4,544.90 (-0.11%)
DOW   35,677.02 (+0.21%)
QQQ   374.10 (-0.84%)
AAPL   148.69 (-0.53%)
MSFT   309.16 (-0.51%)
FB   324.61 (-5.05%)
GOOGL   2,751.33 (-3.04%)
TSLA   909.68 (+1.75%)
AMZN   3,335.55 (-2.90%)
NVDA   227.26 (+0.15%)
BABA   177.70 (+0.16%)
NIO   38.88 (-2.73%)
CGC   13.38 (-4.70%)
GE   104.05 (+0.87%)
AMD   119.82 (+0.41%)
MU   67.51 (-1.65%)
T   25.49 (-1.05%)
F   16.28 (-1.63%)
ACB   7.07 (-4.07%)
DIS   169.42 (-1.12%)
PFE   43.16 (+0.70%)
BA   212.97 (-0.64%)
AMC   36.60 (-6.73%)
S&P 500   4,544.90 (-0.11%)
DOW   35,677.02 (+0.21%)
QQQ   374.10 (-0.84%)
AAPL   148.69 (-0.53%)
MSFT   309.16 (-0.51%)
FB   324.61 (-5.05%)
GOOGL   2,751.33 (-3.04%)
TSLA   909.68 (+1.75%)
AMZN   3,335.55 (-2.90%)
NVDA   227.26 (+0.15%)
BABA   177.70 (+0.16%)
NIO   38.88 (-2.73%)
CGC   13.38 (-4.70%)
GE   104.05 (+0.87%)
AMD   119.82 (+0.41%)
MU   67.51 (-1.65%)
T   25.49 (-1.05%)
F   16.28 (-1.63%)
ACB   7.07 (-4.07%)
DIS   169.42 (-1.12%)
PFE   43.16 (+0.70%)
BA   212.97 (-0.64%)
AMC   36.60 (-6.73%)
S&P 500   4,544.90 (-0.11%)
DOW   35,677.02 (+0.21%)
QQQ   374.10 (-0.84%)
AAPL   148.69 (-0.53%)
MSFT   309.16 (-0.51%)
FB   324.61 (-5.05%)
GOOGL   2,751.33 (-3.04%)
TSLA   909.68 (+1.75%)
AMZN   3,335.55 (-2.90%)
NVDA   227.26 (+0.15%)
BABA   177.70 (+0.16%)
NIO   38.88 (-2.73%)
CGC   13.38 (-4.70%)
GE   104.05 (+0.87%)
AMD   119.82 (+0.41%)
MU   67.51 (-1.65%)
T   25.49 (-1.05%)
F   16.28 (-1.63%)
ACB   7.07 (-4.07%)
DIS   169.42 (-1.12%)
PFE   43.16 (+0.70%)
BA   212.97 (-0.64%)
AMC   36.60 (-6.73%)
ETR:SRT

Sartorius Aktiengesellschaft Stock Forecast, Price & News

€585.00
+11.00 (+1.92 %)
(As of 10/21/2021 12:00 AM ET)
Add
Compare
Today's Range
€567.00
€585.00
50-Day Range
€566.00
€827.00
52-Week Range
€313.00
€834.00
Volume5,697 shs
Average VolumeN/A
Market Capitalization$20.02 billion
P/E Ratio176.79
Dividend Yield0.12%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SRT News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.


Sartorius Aktiengesellschaft logo

About Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
2,020
Year Founded
N/A

Sales & Book Value

Annual Sales
$2.91 billion
Cash Flow
€6.62 per share
Book Value
€15.31 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$20.02 billion
Next Earnings Date
N/A
Optionable
Optionable

MarketRank

Overall MarketRank

0.94 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Sartorius Aktiengesellschaft (ETR:SRT) Frequently Asked Questions

What stocks does MarketBeat like better than Sartorius Aktiengesellschaft?

Wall Street analysts have given Sartorius Aktiengesellschaft a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sartorius Aktiengesellschaft wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Sartorius Aktiengesellschaft's stock been impacted by Coronavirus?

Sartorius Aktiengesellschaft's stock was trading at €182.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SRT shares have increased by 221.4% and is now trading at €585.00.
View which stocks have been most impacted by COVID-19
.

Is Sartorius Aktiengesellschaft a good dividend stock?

Sartorius Aktiengesellschaft pays an annual dividend of €0.70 per share and currently has a dividend yield of 0.12%. The dividend payout ratio of Sartorius Aktiengesellschaft is 21.15%. This payout ratio is at a healthy, sustainable level, below 75%.

Who are Sartorius Aktiengesellschaft's key executives?

Sartorius Aktiengesellschaft's management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 56, Pay $1.46M)
  • Mr. Rainer Lehmann, CFO, Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 46, Pay $825k)
  • Dr. Rene Faber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 46, Pay $714k)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 52, Pay $56k)
  • Mr. John Gerard Mackay, Head of Lab Products & Services Division and Member of Exec. Board (Age 59)
  • Mr. Manfred Werner, Sr. VP of Admin. Organization & Auditing
  • Ms. Mei Wang, Head of Production - China
  • Ms. Patricia Spannagel, Head of Quality Assurance - Mechatronics Division Goettingen
  • Mr. Rashid Maqbool, Head of Production & Certification Department - Denver USA
  • Mr. Manohar Kuppusami, Head of Production Department - India

What other stocks do shareholders of Sartorius Aktiengesellschaft own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius Aktiengesellschaft investors own include American Eagle Outfitters (AEO), Align Technology (ALGN), Gilead Sciences (GILD), Agilent Technologies (A), ACADIA Pharmaceuticals (ACAD), Allianz (ALV), AxoGen (AXGN), Biohaven Pharmaceutical (BHVN), Blueprint Medicines (BPMC) and Cerner (CERN).

What is Sartorius Aktiengesellschaft's stock symbol?

Sartorius Aktiengesellschaft trades on the ETR under the ticker symbol "SRT."

What is Sartorius Aktiengesellschaft's stock price today?

One share of SRT stock can currently be purchased for approximately €585.00.

How much money does Sartorius Aktiengesellschaft make?

Sartorius Aktiengesellschaft has a market capitalization of $20.02 billion and generates $2.91 billion in revenue each year.

How many employees does Sartorius Aktiengesellschaft have?

Sartorius Aktiengesellschaft employs 2,020 workers across the globe.

What is Sartorius Aktiengesellschaft's official website?

The official website for Sartorius Aktiengesellschaft is www.sartorius.com.

Where are Sartorius Aktiengesellschaft's headquarters?

Sartorius Aktiengesellschaft is headquartered at 6200 S Syracuse Way Ste 485, Greenwood Village, Colorado 80111-4737.

How can I contact Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft's mailing address is 6200 S Syracuse Way Ste 485, Greenwood Village, Colorado 80111-4737. The company can be reached via phone at 49 551 308 0.


This page was last updated on 10/22/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.